ClearPoint Neuro (CLPT) Cash from Financing Activities (2011 - 2026)

ClearPoint Neuro has disclosed Cash from Financing Activities across 14 years of filings, most recently posting -$1.8 million for Q1 2026.

• Cash from Financing Activities for Q1 2026 came in at -$1.8 million, down 35.46% year-over-year; the trailing twelve-month figure through Mar 2026 was $49.7 million (up 542.69% YoY), and the FY2025 annual result was $50.2 million, up 710.78% from the prior year.
• Cash from Financing Activities came in at -$1.8 million for Q1 2026 at ClearPoint Neuro, down from $19.6 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $32.0 million in Q2 2025 to a low of -$10.1 million in Q3 2024.
• The 5-year median for Cash from Financing Activities is $96000.0 (2023), against an average of $3.5 million.
• Peak annual rise in Cash from Financing Activities reached 321160.0% in 2024, while the deepest fall reached 10956.04% in 2024.
• ClearPoint Neuro's Cash from Financing Activities stood at $222000.0 in 2022, then tumbled by 30.18% to $155000.0 in 2023, then plunged by 76.13% to $37000.0 in 2024, then soared by 52775.68% to $19.6 million in 2025, then sank by 109.43% to -$1.8 million in 2026.
• The last three Cash from Financing Activities figures came in at -$1.8 million (Q1 2026), $19.6 million (Q4 2025), and $32.0 million (Q2 2025), per Business Quant data.